Purchase Order 1333ND26PNB640497

<p>The Food and Drug Administration awarded a purchase order to Qiagen, LLC for an automated DNA/RNA extraction system with viral nucleic acid kits valued at $37,207.54 on June 15, 2022, with ultimate completion by June 10, 2026. Work is performed in Germantown, Maryland. The procurement was issued under a pre-solicitation posted May 3, 2022 with a closing date of May 10, 2022. The order carries firm fixed price terms with no set-aside designation.</p>

The National Institute of Standards and Technology awarded a purchase order to Qiagen, LLC for $100,000.00 on September 18, 2024, covering a QIAGEN Full Instrument Service Agreement for Illumina MiSeq FGX DNA Sequencing System and QIAGEN Standard Instrument Service Agreement for Illumina ForenseQ Universal Analysis Server. No set-aside was used. Performance occurs in Germantown, Maryland, with ultimate completion on September 17, 2029. The order is priced on a firm fixed price basis and...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for an annual service agreement for nucleic acid extraction equipment, valued at $10,410.00, with an award date of May 15, 2020 and completion date of May 14, 2021. Work is performed in Germantown, Maryland. The order is priced on a firm fixed price basis with no set-aside designation.</p>

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC for a full service agreement on QIAXTRACTOR/QIACUBE HT systems. The contract has a ceiling value of $10,698.00 and a period of performance through April 30, 2022. Qiagen, LLC is a division of the parent company Qiagen N.V., which is an international provider of sample and assay technologies...

<p>The National Human Genome Research Institute awarded a purchase order to Qiagen, LLC for $10,456.60 on August 16, 2016, with firm fixed price, no set-aside. Place of performance is Bethesda, Maryland. The order calls for molecular diagnostics consumables and reagents, including DNA/RNA extraction kits and related laboratory supplies. Ultimate completion date is December 22, 2020.</p>

This is a definitive contract awarded by the U.S. Army Criminal Investigation Command (CID) to Qiagen, LLC on January 1, 2023. The contract, valued at $134,765.58, is for the delivery of the EZ1 ADVANCED XL system, which is a sample preparation platform used for DNA extraction and purification. The contract has a firm fixed price pricing type and a completion date of December 31, 2024. Qiagen, LLC is a subsidiary of the parent company Qiagen N.V., an international provider of sample and assay...

This is a $12,060 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is for maintenance services on Qiagen's EZ2 Connect and QIAcuity One instruments used for isolation and analysis of cell-free DNA. The contract has an ultimate completion date of August 15, 2026. Qiagen has established itself as a critical...

This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and bioinformatics solutions. The contract has a ceiling value of $4,909.67 and a period of performance through April 11, 2025. The contract covers the &quot;EXERCISE FULL AGREEMENT FOR EZ1 ADVANCED&quot; requirement, which likely involves the provision of Qiagen's EZ1 DNA/RNA extraction equipment and...

The Department of Commerce National Oceanic and Atmospheric Administration (NOAA) awarded a firm-fixed-price purchase order to Qiagen, LLC for the purchase of 20 Qiagen DNeasy 96 Blood &amp; Tissue Kits at a total potential value of $59,592.00. The kits must be compatible with liquid handling automation and use a silica-based system for nucleic acid purification. Delivery is required by May 30, 2024 to a NOAA facility in Germantown, Maryland. This contract has no set-aside designation. Qiagen,...

<p>The National Institute of Mental Health awarded a purchase order to Qiagen, LLC for a QIAcube Connect automated nucleic acid extraction instrument valued at $30,875.78 on August 3, 2026. Performance will occur in Bethesda, Maryland, with ultimate completion by August 2, 2027. The order carries firm fixed pricing and no set-aside designation.</p>